TABLE 6.
HVR-1 genetic parameters on treatment in patients with different therapeutic responses
| Sample | Genotype | Daya | RNA | No. | Complexity
|
Intersample analysisb (SD)
|
Intrasample analysisc
|
Responsed
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nucleotide | Amino acid | d | dS | dN | dN/dS | d | dS | dN | dN/dS | EVR | SVR | |||||
| LIV14 | 1a | −30 | 3.79E+05 | 12 | 0.697 | 0.635 | 0.110 (0.027) | 0.043 (0.027) | 0.141 (0.033) | 3.28 | 0.110 | 0.043 | 0.141 | 3.28 | N | N |
| 150 | 4.76E+05 | 13 | 0.693 | 0.693 | 0.131 (0.029) | 0.026 (0.017) | 0.177 (0.046) | 6.81 | 0.138 | 0.039 | 0.181 | 4.64 | ||||
| LIV15 | 1a | −30 | 4.16E+05 | 12 | 0.779 | 0.703 | 0.063 (0.017) | 0.044 (0.020) | 0.071 (0.023) | 1.61 | 0.063 | 0.044 | 0.071 | 1.61 | N | N |
| 150 | 2.50E+05 | 12 | 0.450 | 0.000 | 0.010 (0.006) | 0.043 (0.026) | 0.000 (0.000) | 0.00 | 0.063 | 0.142 | 0.040 | 0.28 | ||||
| LIV16 | 1a | −30 | 3.67E+05 | 11 | 0.737 | 0.737 | 0.114 (0.024) | 0.087 (0.034) | 0.126 (0.034) | 1.45 | 0.114 | 0.087 | 0.126 | 1.45 | N | N |
| 90 | 5.70E+05 | 14 | 0.376 | 0.376 | 0.027 (0.011) | 0.000 (0.000) | 0.037 (0.016) | NAe | 0.095 | 0.057 | 0.109 | 1.91 | ||||
| 270 | 5.57E+05 | 12 | 0.668 | 0.331 | 0.033 (0.013) | 0.054 (0.027) | 0.026 (0.014) | 0.48 | 0.177 | 0.213 | 0.165 | 0.77 | ||||
| LIV18 | 1a | −30 | 3.72E+05 | 12 | 0.796 | 0.607 | 0.076 (0.021) | 0.078 (0.041) | 0.075 (0.027) | 0.96 | 0.076 | 0.078 | 0.075 | 0.96 | C | N |
| 29 | 3.30E+04 | 10 | 0.473 | 0.473 | 0.133 (0.031) | 0.150 (0.058) | 0.128 (0.042) | 0.85 | 0.129 | 0.153 | 0.123 | 0.80 | ||||
| 60 | 3.34E+02 | 12 | 0.432 | 0.432 | 0.123 (0.032) | 0.175 (0.082) | 0.106 (0.028) | 0.61 | 0.163 | 0.256 | 0.135 | 0.53 | ||||
| LIV04 | 1a | −30 | 5.70E+05 | 12 | 0.115 | 0.115 | 0.004 (0.003) | 0.000 (0.000) | 0.006 (0.004) | NA | 0.004 | 0.000 | 0.006 | NA | C | C |
| 15 | 1.38E+03 | 13 | 0.917 | 0.761 | 0.050 (0.016) | 0.033 (0.019) | 0.058 (0.020) | 1.76 | 0.035 | 0.017 | 0.043 | 2.53 | ||||
| LIV12 | 1a | −30 | 2.44E+05 | 13 | 0.592 | 0.592 | 0.018 (0.008) | 0.007 (0.007) | 0.023 (0.012) | 3.29 | 0.018 | 0.007 | 0.023 | 3.29 | C | C |
| 1 | 2.50E+04 | 12 | 0.442 | 0.115 | 0.010 (0.005) | 0.025 (0.014) | 0.006 (0.004) | 0.24 | 0.228 | 0.065 | 0.296 | 4.55 | ||||
| 7 | 1.49E+02 | 11 | 0.127 | 0.127 | 0.002 (0.002) | 0.000 (0.000) | 0.003 (0.003) | NA | 0.225 | 0.053 | 0.298 | 5.63 | ||||
| LIV02 | 1a | −30 | 1.40E+05 | 10 | 0.141 | 0.000 | 0.002 (0.003) | 0.011 (0.012) | 0.000 (0.000) | 0.00 | 0.002 | 0.011 | 0.000 | 0.00 | C | N |
| 3 | 3.62E+04 | 13 | 0.308 | 0.308 | 0.147 (0.032) | 0.061 (0.045) | 0.181 (0.060) | 2.97 | 0.094 | 0.045 | 0.113 | 2.51 | ||||
| 29 | 8.46E+02 | 13 | 0.309 | 0.209 | 0.007 (0.005) | 0.014 (0.017) | 0.005 (0.004) | 0.36 | 0.356 | 0.166 | 0.430 | 2.59 | ||||
Day indicates treatment day when the serum sample for RNA load and quasispecies testing was drawn.
Values for individual baseline and follow-up samples.
Values for composite of baseline and follow-up samples.
C, a response was achieved; N, a response was not achieved.
NA, not applicable.